|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 950 F STREET, NW |
Address2 | SUITE 500 |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Minneapolis |
State | MN |
Zip Code | 55432 |
Country | USA |
|
5. Senate ID# 24817-12
|
||||||||
|
6. House ID# 310490000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Kristina Pisanelli |
Date | 4/20/2018 1:22:58 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to competitive bidding for DME products.
Issues related to Medicare policies on continuous glucose monitoring.
Issues related to Medicare policies on drug coated balloons.
Issues related to value based health care.
Issues related to opioids/chronic pain.
Issues related to breakthrough technologies.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Kristina |
Pisanelli |
|
|
|
Todd |
Gillenwater |
|
|
|
Whitney |
Gardiner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 184, Protect Medical Innovation Act, provisions related to the repeal of the medical device tax.
S. 108, Medical Device Access and Innovation Protection Act, provisions related to the continued suspension and repeal of the medical device tax.
H.R. 4617, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium on the medical device excise tax, provisions related to the continued suspension and repeal of the medical device tax.
H.R. 195, Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes, provisions related to the suspension of the medical device tax.
Tax policy proposals relating to Puerto Rico.
Issues related to implementation of P.L. 115-97, the Tax Cuts and Jobs Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jessica |
Battaglia |
|
|
|
Kristina |
Pisanelli |
|
|
|
Todd |
Gillenwater |
|
|
|
Rosemary |
Garza |
|
|
|
Whitney |
Gardiner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Issues related to price caps for medical technologies in India.
Issues related to free trade agreements.
Issues related to proposed tariffs.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jessica |
Battaglia |
|
|
|
Kristina |
Pisanelli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 787, The Telehealth Innovation and Improvement Act of 2017.
S. 870, Creating High Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017.
H.R. 1148, The Furthering Access to Stroke Telemedicine Act of 2017.
Issues related to heart valve disease.
Issues related to opioids/chronic pain.
Issues related to value based health care and modernization of fraud and abuse laws.
Issues related to the re-authorization of the pandemic all hazardous preparedness act.
Issues related to natural disaster recovery efforts.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rosemary |
Garza |
|
|
|
Kristina |
Pisanelli |
|
|
|
Todd |
Gillenwater |
|
|
|
Whitney |
Gardiner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AVI
16. Specific lobbying issues
H.R. 2997, The 21st Century Aviation, Innovation, Reform Reauthorization, provisions related to lithium batteries.
S. 1405, Federal Aviation Administration Reauthorization Act of 2017, provisions related to lithium batteries.
H.R. 4643, The Safe Air Transport of Hazardous Materials Act of 2017, provisions related to lithium batteries.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rosemary |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues related to VA procurement and devices.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rosemary |
Garza |
|
|
|
Todd |
Gillenwater |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
S. 1656, Medical Device Cybersecurity Act, provisions related to cybersecurity and medical technology.
S. 1691, Internet of Things (IoT) Cybersecurity Improvement Act, provisions related to cybersecurity and medical technology.
S. 2020, The Cyber Shield Act, provisions related to cybersecurity and medical technology.
H.R. 3985, Internet of Things Resilience Partnership Act, provisions related to medical technology.
H.R. 4191, the HHS Cybersecurity Modernization Act, provisions related to cybersecurity and medical technology.
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jessica |
Battaglia |
|
|
|
Kristina |
Pisanelli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
S. 2098, the Foreign Investment Risk Review Modernization Act, provisions related to the Committee on Foreign Investment in the U.S. (CFIUS).
H.R. 4311, the Foreign Investment Risk Review Modernization Act, provisions related to the Committee on Foreign Investment in the U.S. (CFIUS).
S. 2039, the Disclosing Foreign Influence Act, provisions related to the Foreign Agents Registration Act (FARA).
H.R. 4170, the Disclosing Foreign Influence Act, provisions related to the Foreign Agents Registration Act (FARA).
S. 625, the Foreign Agents Registration Modernization and Enforcement Act, provisions related to the Foreign Agents Registration Act (FARA).
H.R. 2811, the Foreign Agents Registration Modernization and Enforcement Act, provisions related to the Foreign Agents Registration Act (FARA).
Issues related to sanctions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jessica |
Battaglia |
|
|
|
Kristina |
Pisanelli |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 1625, Consolidated Appropriations Act of 2018, provisions related to the FAA extension and opioids funding.
H.R. 1892, Bipartisan Budget Act of 2018, Advancing Chronic Care, Extenders, and Social Services (ACCESS) Act, provisions related to telehealth and stroke.
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rosemary |
Garza |
|
|
|
Todd |
Gillenwater |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |